Why did Pfizer choose the OU to certify ELELYSO kosher?
The OU is a not-for-profit organization headquartered in New York City that serves the Jewish community on multiple levels. The OU Kosher division is the largest and most well-known kosher certification agency in the world. Although injectable medicines do not require kosher certification, the OU agreed to grant kosher certification to show support for Pfizer’s commitment to the Jewish community afflicted with Type 1 Gaucher disease.
Products the OU certifies kosher—and the facilities making them—are rigorously monitored, regularly inspected, and held to high-quality standards. The organization’s mark on kosher-certified products signifies the products’ rigorous inspection and adherence to those high-quality standards. The OU certifies close to 1 million products in more than 80 countries around the world.
Kosher certification from the OU is a multistep process.
First, Pfizer contacted the OU to apply for kosher certification. Then, the ingredients and manufacturing facility were subject to a rigorous inspection. This included an analysis of the raw materials and the processes used to manufacture ELELYSO. The OU then certified the kosher status of the medication.
The OU will annually reinspect the manufacturing and ingredients of ELELYSO to ensure they remain kosher.
Kosher certification does not involve blessings or other religious rites.
The kosher certification by the OU is global.